Delivery Order SPE2DB22D3016-SPE2DB25FBBF0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Yervoy 50 mg/10 ml vial (10 ml), a prescription medication, with a ceiling value of $22,870.92. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,142,126 units of the medication YERVOY 50 MG/10 ML VIAL 10ML. The contract has a ceiling value of $22,870.92 and a period of performance through May 27, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YERVOY 200 MG/40 ML VIAL 40ML, with a ceiling value of $68,873.97 and a period of performance through August 1, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Yervoy 50 mg/10 ml vials, a medication used for the treatment of certain types of cancer. The contract has a firm fixed price and a ceiling value of $22,870.92. It is a non-set-aside contract, indicating open competition. The contract has an ultimate completion date of May 6, 2025 and was awarded on April...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,870.92 firm-fixed-price delivery order is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a specialty medication. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,870.92, is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has a completion date of April 8, 2025 and is a firm fixed-price delivery order. There is no set-aside designation on this contract. Amerisourcebergen...
- This is a $11,435.46 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,435.46, is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a prescription medication, with a ceiling value of $22,870.92 and a performance period ending on July 14, 2025. The contract is a firm fixed-price delivery order, which means the price is set and not subject to adjustment. This award is not...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has a ceiling value of $10,811.72 and a period of performance through April 17, 2024. This award is not designated as a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBBF0Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 mg/40 ml vials of the drug Yervoy. The contract has a firm fixed price, a ceiling value of $25,022.41, and a period of performance through July 28, 2025. The contract is not set aside for any small business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 7/7/25 |